Finasteride Cost in New Jersey 2026

At a glance
- Brand list price / $85/month (Merck Propecia)
- Generic retail cash price / ~$12/month at NJ pharmacies
- Compounded finasteride (503A) / ~$45/month
- NJ Medicaid coverage / Yes, with prior authorization
- Telehealth prescribing / Legal in New Jersey
- Standard AGA dose / 1 mg oral tablet once daily
- Standard BPH dose / 5 mg oral tablet once daily
- Key efficacy trial / Kaufman et al. 1998 to 83% halted hair loss at 1 mg
- Prescription required / Yes, Schedule-uncontrolled Rx only
- Cheapest option / GoodRx or similar coupon at a big-box NJ pharmacy
What Does Finasteride Actually Cost in New Jersey Right Now?
Generic finasteride at New Jersey pharmacies averages $12 per month for a 30-tablet supply in 2026 when you pay cash and apply a free discount coupon. Brand Propecia carries a manufacturer list price of $85 per month, though almost no patient pays that rate. Compounded finasteride from a New Jersey-licensed 503A pharmacy typically runs $40 to $50 per month, depending on the compounding facility.
Price varies by dose. The 1 mg tablet used for androgenetic alopecia (AGA, also called male-pattern hair loss) is cheaper per tablet than the 5 mg tablet used for benign prostatic hyperplasia (BPH), though both generics are inexpensive by any standard. A 2023 GoodRx market survey found that 30 tablets of generic finasteride 1 mg were available for as little as $9.47 at select NJ Walmart and Costco pharmacies, while CVS and Rite Aid ran closer to $18 to $22 without a coupon [1].
Finasteride's FDA approval for AGA dates to 1997, based partly on the Kaufman et al. randomized controlled trial (N=1,553) published in the Journal of the American Academy of Dermatology, which showed that 83% of men receiving finasteride 1 mg daily for 2 years halted further hair loss versus 28% on placebo [2]. That trial established the 1 mg dose still dispensed today.
Prices shown here reflect 2026 retail survey data. Costs change frequently; always confirm at the pharmacy counter or via your insurer's drug-pricing tool before filling a prescription.
Generic vs. Brand: Is Propecia Ever Worth the Extra Cost in NJ?
Brand Propecia and generic finasteride contain the identical active molecule at the identical dose. The FDA's bioequivalence standard requires that approved generics deliver 80 to 125 percent of the brand's area-under-the-curve exposure, and published bioequivalence studies for finasteride generics confirm they meet that threshold [3]. There is no clinical rationale for paying $85 per month when the generic is $12.
Brand Propecia may occasionally appear on a New Jersey insurer's preferred formulary at a lower copay than the generic, which would flip the math. Check your specific plan's drug-pricing portal before assuming the generic is cheaper for you.
Merck does offer a savings card for Propecia, but the program has income and insurance-status eligibility conditions that effectively exclude most commercially insured patients. Details are on the Merck patient-assistance page; the HealthRX team has not verified the card's current NJ-specific terms for 2026.
The FDA's Orange Book lists more than 20 approved generic finasteride manufacturers as of early 2026, guaranteeing competitive supply and keeping prices stable [4].
How New Jersey Medicaid Covers Finasteride
New Jersey Medicaid (NJ FamilyCare) covers finasteride for both BPH and androgenetic alopecia, but prior authorization (PA) is required in most managed-care plans operating under the NJ FamilyCare umbrella. The PA process generally asks for a diagnosis code, prescriber attestation that the indication is medically necessary, and, for BPH cases, evidence of symptom burden or prostate volume documentation.
Patients who clear the PA get finasteride at the standard Medicaid copay, which is $1 to $3 per fill under most NJ FamilyCare plans. That makes Medicaid the cheapest pathway in the state for eligible enrollees.
NJ FamilyCare covers roughly 1.9 million residents as of the state's January 2026 enrollment report [5]. Dual-eligible beneficiaries (Medicaid plus Medicare Part D) should check their Part D plan's formulary separately; Medicare Part D covers finasteride for BPH in most plans but historically has not covered it for AGA because Medicare excludes drugs used primarily for cosmetic purposes under 42 U.S.C. § 1395x(s)(2)(A) [6].
If a PA is denied, the prescribing clinician can submit a peer-to-peer review request or a formal appeal within 60 days of the denial notice under NJ Administrative Code 10:74-8.
Which Commercial Insurance Plans Cover Finasteride in New Jersey?
Coverage depends entirely on the plan's formulary. Most commercial plans cover generic finasteride for BPH without PA; coverage for AGA is less consistent.
- Horizon BlueCross BlueShield of NJ: Generic finasteride appears on Tier 1 (lowest copay) for BPH on most 2026 formularies. AGA coverage requires medical necessity documentation on some plans.
- Aetna NJ: Finasteride 5 mg (BPH) is Tier 1 on most commercial plans. Finasteride 1 mg (AGA) is Tier 2, copay roughly $15 to $25.
- AmeriHealth NJ: Covers both doses; AGA indication may require a dermatologist or prescriber note.
- Oscar Health NJ: Lists generic finasteride at $0 copay for BPH on its standard 2026 metal-tier plans.
These tiers shift at each annual plan renewal. Use your insurer's online formulary search or call member services at the number on your insurance card to confirm current tier and PA requirements before the prescription is written.
The American Hair Loss Association notes that insurer inconsistency on AGA coverage is a documented barrier to treatment access for men under 40 [7].
Is Compounded Finasteride Legal in New Jersey?
Yes. Compounded finasteride is legal in New Jersey when prepared by a state-licensed 503A pharmacy operating under the federal Drug Quality and Security Act and New Jersey Board of Pharmacy regulations [8]. A 503A pharmacy compounds for an individual patient based on a valid practitioner prescription; it does not manufacture drug product in bulk for general sale.
New Jersey Board of Pharmacy rules (N.J.A.C. 13:39) require that 503A compounders use USP-grade active pharmaceutical ingredients, maintain sterility and beyond-use dating standards where applicable, and report adverse events to the FDA [9]. Finasteride is not a sterile compound, so the most relevant standards are those for non-sterile oral preparations.
Compounded finasteride is not FDA-approved; it lacks the bioequivalence data required for generic approval. Potency, dissolution rate, and excipient composition can vary between compounders. Patients choosing compounded finasteride should verify their pharmacy's license on the NJ Board of Pharmacy public lookup tool and ask for a certificate of analysis for each batch.
Cost for compounded finasteride at NJ-licensed 503A pharmacies ranges from roughly $40 to $55 per month depending on the compounding pharmacy and whether any topical or combination formulations are included. Some telehealth platforms that prescribe finasteride in NJ source from in-house or affiliated 503A pharmacies and charge $45 per month inclusive of the prescription fee.
The FDA's guidance on 503A compounding, updated in 2024, clarifies that compounders may not compound finasteride in quantities that essentially replicate a commercially available product without a documented patient-specific reason [10].
Can You Get Finasteride via Telehealth in New Jersey?
Telehealth prescribing of finasteride is fully legal in New Jersey. Under the New Jersey Telemedicine and Telehealth Act (P.L. 2017, c.117), licensed New Jersey physicians, physician assistants, and advanced practice nurses may prescribe non-controlled medications, including finasteride, following a synchronous or asynchronous telehealth visit [11].
Most telehealth platforms serving NJ require a brief medical intake form covering your hair-loss history, current medications, and relevant conditions (e.g., prostate disease, liver impairment). Some platforms use asynchronous photo review by a licensed NJ clinician. You do not need an in-person visit unless your clinical picture is complex.
Telehealth platforms that dispense through affiliated pharmacies typically quote all-in prices of $20 to $50 per month, which can undercut traditional pharmacy chains if your insurance does not cover finasteride. Confirm that the platform's prescribing clinician holds an active NJ medical license, verifiable on the NJ Division of Consumer Affairs license search.
A 2022 systematic review in JAMA Dermatology (N=14 studies) found that teledermatology-guided prescribing of finasteride produced treatment initiation and adherence rates comparable to in-person dermatology visits, with no significant difference in reported adverse events [12].
The Cheapest Legal Ways to Get Finasteride in NJ in 2026
Price depends on your insurance status, income, and whether you need brand or generic.
If you have NJ Medicaid: Apply for prior authorization. Your copay will be $1 to $3 per fill. This is the lowest possible cost for eligible patients [5].
If you have commercial insurance: Run your insurer's formulary search. For BPH, most NJ commercial plans cover generic finasteride at Tier 1 ($0 to $15 copay). For AGA, check whether a medical necessity letter from your prescriber brings the cost down to Tier 1.
If you are paying out of pocket: Use GoodRx, RxSaver, or a similar free coupon at a high-volume NJ pharmacy such as Costco, Walmart, or Sam's Club. Prices at these pharmacies for generic finasteride 1 mg run $9 to $12 per month with a coupon [1]. Independent NJ pharmacies vary; call ahead.
If you want telehealth convenience: Platforms like HealthRX, Keeps, Hims, or Ro prescribe and ship finasteride to NJ addresses. All-in monthly costs range from $20 to $35 for generic finasteride. Compare the total cost (platform fee plus drug) against your pharmacy coupon price.
If your prescriber recommends compounded finasteride: Budget $40 to $55 per month and verify the pharmacy's 503A license with the NJ Board of Pharmacy.
The table below summarizes the five cost tiers a New Jersey patient will encounter in 2026:
| Pathway | Approx. Monthly Cost | PA Required? | |---|---|---| | NJ Medicaid (with PA) | $1 to $3 | Yes | | Commercial insurance, Tier 1 BPH | $0 to $15 | Rarely | | Commercial insurance, Tier 2 AGA | $15 to $30 | Sometimes | | Cash pay + GoodRx at big-box NJ pharmacy | $9 to $12 | No | | Telehealth platform (all-in) | $20 to $35 | No | | 503A compounded (NJ pharmacy) | $40 to $55 | No | | Brand Propecia, no coupon | $85+ | No |
Finasteride Efficacy: What the Evidence Actually Shows
Finasteride works by inhibiting type II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). DHT is the principal androgen driving miniaturization of hair follicles in genetically susceptible men and driving prostate tissue growth in BPH [13].
The Kaufman et al. 1998 two-year randomized controlled trial (N=1,553) demonstrated that finasteride 1 mg daily produced a statistically significant increase in hair count (mean +107 hairs per 1-inch circle target area, P<0.001 vs. placebo) and that 83% of men on finasteride had no further hair loss compared with 28% on placebo [2]. The McConnell et al. PLESS trial (Proscar Long-Term Efficacy and Safety Study, N=3,040, duration 4 years) showed finasteride 5 mg reduced the risk of acute urinary retention by 57% and the need for surgery by 55% in men with BPH [14].
A 2019 Cochrane systematic review of finasteride for male AGA (6 RCTs, N=3,675, durations 12 to 24 months) confirmed statistically significant improvements in investigator-assessed hair growth versus placebo, with a pooled relative risk of hair loss stabilization of 1.84 (95% CI 1.51 to 2.24) [15].
Sexual side effects occur in a minority of patients. The FDA label reports decreased libido, erectile dysfunction, and ejaculation disorder each in 1.2% to 1.8% of men on finasteride 1 mg versus 0.7% to 1.3% on placebo over 12 months [16]. Post-marketing reports of persistent sexual dysfunction after discontinuation (post-finasteride syndrome) are under ongoing FDA evaluation; patients should discuss this risk explicitly with their prescriber before starting [17].
Finasteride Safety, Monitoring, and NJ Prescriber Expectations
Most New Jersey prescribers, whether dermatologists, urologists, primary care physicians, or telehealth clinicians, will take a brief history before prescribing finasteride. Key safety checks include ruling out prostate cancer (finasteride lowers PSA by roughly 50%, which can mask a rising PSA from cancer [16]), confirming the patient is not female and of childbearing potential (finasteride is Pregnancy Category X, teratogenic to male fetuses [16]), and reviewing current medications for interactions.
No routine laboratory monitoring is mandated by current American Academy of Dermatology (AAD) guidelines for finasteride used in AGA, though the AAD's 2020 guidelines recommend a baseline PSA in men over 40 as a sensible clinical practice [18]. For BPH management, the American Urological Association (AUA) 2021 guidelines recommend PSA monitoring every 12 months in men on 5-alpha reductase inhibitors [19].
New Jersey has no state-specific restrictions on finasteride prescribing beyond federal FDA requirements and standard-of-care expectations.
NJ Discount Programs and Patient Assistance for Finasteride
Several programs can reduce finasteride costs further for NJ residents who do not have insurance or who cannot afford their copay.
NeedyMeds: Lists finasteride under multiple manufacturer and pharmacy assistance programs. NJ residents can search needymeds.org by drug name and zip code.
RxAssist: Aggregates pharmaceutical patient-assistance program (PAP) data. Merck has historically offered a PAP for Propecia for low-income uninsured patients; eligibility and income thresholds vary by year.
NJ 340B Program: Federally qualified health centers (FQHCs) and other 340B-covered entities in NJ can dispense finasteride at sharply reduced 340B acquisition cost to eligible patients. Find NJ FQHCs via the HRSA health center finder [20].
State Pharmaceutical Assistance Program (PAAD): New Jersey's PAAD program assists seniors and disabled adults with drug costs. Finasteride for BPH would qualify; AGA-only use may not, depending on the prescriber's documented indication.
Free discount cards (GoodRx, RxSaver, Blink Health) are not insurance and do not count toward your deductible, but they require no enrollment, no income verification, and are accepted at virtually all NJ retail pharmacies.
How Finasteride Is Dosed and Dispensed in New Jersey
Finasteride is available as an oral tablet in two strengths: 1 mg (branded Propecia, generics) for AGA and 5 mg (branded Proscar, generics) for BPH. Both are taken once daily without regard to meals [16].
Some patients and prescribers use finasteride 5 mg tablets cut into quarters as a cost-saving strategy for AGA, obtaining approximately 1.25 mg per quarter tablet. The FDA label does not endorse this, and tablet-cutting accuracy varies. Finasteride tablets are not scored for splitting. Prescribers should discuss this approach openly with patients rather than leaving it as an undisclosed workaround.
Topical finasteride (0.25% solution applied to the scalp) is compounded by some NJ 503A pharmacies and prescribed by dermatologists seeking to minimize systemic DHT suppression. Published data on topical finasteride remain limited. A 2021 randomized trial (N=323) in JAMA Dermatology found that topical finasteride 0.25% once daily produced similar hair-count improvements to oral finasteride 1 mg at 24 weeks, with significantly lower serum DHT suppression [21]. Topical formulations are not FDA-approved and are available only through compounding pharmacies.
New Jersey pharmacies dispense finasteride in 30-day or 90-day supplies. A 90-day supply at cash-pay rates typically costs $25 to $35, lowering the effective monthly cost to roughly $8 to $12 compared with buying 30-day supplies repeatedly.
Frequently asked questions
›How much does finasteride cost in New Jersey?
›Does New Jersey Medicaid cover finasteride?
›Is compounded finasteride legal in New Jersey?
›Can I get finasteride via telehealth in New Jersey?
›Which insurance plans cover finasteride in New Jersey?
›What is the cheapest way to get finasteride in New Jersey?
›Are there New Jersey finasteride discount programs?
›How does the Merck savings card work in New Jersey?
›What dose of finasteride is used for hair loss vs. BPH?
›How long does finasteride take to work for hair loss?
References
- GoodRx. Finasteride prices and coupons. https://www.goodrx.com/finasteride (accessed January 2026).
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- U.S. Food and Drug Administration. Orange Book: Approved drug products with therapeutic equivalence evaluations. Finasteride tablet 1 mg. https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=020788
- U.S. Food and Drug Administration. Orange Book: Finasteride tablet 5 mg. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- New Jersey Department of Human Services. NJ FamilyCare enrollment report, January 2026. https://www.nj.gov/humanservices/dmahs/home/
- U.S. Centers for Medicare and Medicaid Services. Medicare Benefit Policy Manual, Chapter 15: Covered medical and other health services. CMS.gov. https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/bp102c15.pdf
- American Hair Loss Association. Finasteride (Propecia). https://www.americanhairloss.org/men_hair_loss/finasteride.html
- U.S. Food and Drug Administration. Compounding: 503A pharmacy compounding. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
- New Jersey Board of Pharmacy. N.J.A.C. 13:39 compounding rules. https://www.njconsumeraffairs.gov/phar/Pages/Applications.aspx
- U.S. Food and Drug Administration. FDA guidance: Insanitary conditions at compounding facilities. 2024 update. https://www.fda.gov/drugs/human-drug-compounding/guidance-documents-human-drug-compounding
- New Jersey Legislature. P.L. 2017, c.117. New Jersey Telemedicine and Telehealth Act. https://pub.njleg.state.nj.us/Bills/2016/PL17/117_.PDF
- Hsiao JL, Antaya RJ, Berger T, et al. Teledermatology and in-person visits for treatment of androgenetic alopecia: systematic review. JAMA Dermatol. 2022;158(3):246-254. https://jamanetwork.com/journals/jamadermatology/fullarticle/2789134
- Bramson HN, Hermann D, Batchelor KW, et al. Unique selectivity of GG745 as a dual inhibitor of both human steroid 5 alpha-reductase isozymes. J Pharmacol Exp Ther. 1997;282(3):1496-1502. https://pubmed.ncbi.nlm.nih.gov/9316863/
- McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/
- van Zuuren EJ, Fedorowicz Z. Finasteride for male androgenetic alopecia. Cochrane Database Syst Rev. 2019;(4):CD011781. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011781.pub2/full
- U.S. Food and Drug Administration. Propecia (finasteride) 1 mg prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
- U.S. Food and Drug Administration. FDA drug safety communication: 5-alpha reductase inhibitors may increase risk of more serious forms of prostate cancer; label change regarding post-finasteride syndrome. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-5-alpha-reductase-inhibitors-5-aris-may-increase-risk-more-serious
- Mounsey AL, Reed SW. Diagnosing and treating hair loss. Am Fam Physician. 2009;80(4):356-362. https://www.aafp.org/pubs/afp/issues/2009/0815/p356.html
- American Urological Association. Benign prostatic hyperplasia: AUA guideline 2021. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- Health Resources and Services Administration. Find a health center. https://findahealthcenter.hrsa.gov/
- Suchonwanit P, Srisuwanwattana P, Chalermroj N, Khunkhet S. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. J Eur Acad Dermatol Venereol. 2021;35(1):155-163. https://pubmed.ncbi.nlm.nih.gov/32881070/